跳至主要内容
临床试验/ITMCTR2100005040
ITMCTR2100005040招募中4 期

A multi-center randomized controlled clinical study of HIFU combined with Guizhi Poria Capsule in sequential treatment of uterine fibroids

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 49(—)
性别
Female

入选标准

  • 1. Aged 20 to 49 years, regular menstrual cycle, 21-35 days;
  • 2. Those who meet the IUF diagnostic criteria and the diameter of fibroids is <=8cm and >=3cm;
  • 3. Those who meet the conditions of HIFU treatment and receive HIFU treatment;
  • 4. Those who have no requirement for childbirth during treatment;
  • 5. Subjects gave informed consent and signed an informed consent form voluntarily.

排除标准

  • 1. Those who are allergic to the relevant drug ingredients in this study;
  • 2. Patients with severe primary diseases and mental illnesses such as severe heart, cerebrovascular, liver, kidney and hematopoietic system, diabetes, and thyroid diseases;
  • 3. Submucosal fibroids, subserosal fibroids, adenomyosis, adenomyoma, and malignant transformation;
  • 4. Those who have participated in other clinical researches within the past month, or are using similar drugs and related treatments within one month, and the efficacy of the drugs is difficult to judge;
  • 5. The investigator believes that it is not suitable to participate in this clinical research.

研究者

发起方
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

相似试验

A multi-center randomized controlled clinical study... | 临床试验